Stryker Work in process increased by 1.4% to $442.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $391.00M to $442.00M. Over 4 years (FY 2020 to FY 2024), Work in process shows an upward trend with a 7.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $264.00M | $274.00M | $264.00M | $298.00M | $315.00M | $309.00M | $348.00M | $366.00M | $391.00M | $342.00M | $330.00M | $372.00M | $380.00M | $391.00M | $336.00M | $398.00M | $436.00M | $442.00M |
| QoQ Change | — | +3.8% | -3.6% | +12.9% | +5.7% | -1.9% | +12.6% | +5.2% | +6.8% | -12.5% | -3.5% | +12.7% | +2.2% | +2.9% | -14.1% | +18.5% | +9.5% | +1.4% |
| YoY Change | — | — | — | — | +19.3% | +12.8% | +31.8% | +22.8% | +24.1% | +10.7% | -5.2% | +1.6% | -2.8% | +14.3% | +1.8% | +7.0% | +14.7% | +13.0% |
| % of Inventories | 7.7% | 8.0% | 8.0% | 8.5% | 8.4% | 8.0% | 8.7% | 8.4% | 8.5% | 7.0% | 6.8% | 7.4% | 7.5% | 7.4% | 7.0% | 7.8% | 8.2% | 8.2% |
| Share Change | — | +0.3pp | -0.0pp | +0.5pp | -0.1pp | -0.4pp | +0.8pp | -0.3pp | +0.1pp | -1.5pp | -0.2pp | +0.6pp | +0.1pp | -0.1pp | -0.4pp | +0.8pp | +0.4pp | -0.0pp |
We use cookies for analytics. See our Privacy and Cookie Policy.